To note, AML, thyroid cancer and PPGL show the lowest tumor mutational burden amongst all neoplasia (n = 10–14) [41], something that indicates a low number of passenger variants and stresses the relevance for tumor development of mutated genes, such as DNMT3A. The gene discussed is DNMT3A; the disease is thyroid gland carcinoma.